| Secondary |
| Epilepsy |
44.9% |
| Convulsion |
10.9% |
| Intractable Epilepsy |
8.2% |
| Rectal Cancer |
5.4% |
| Drug Use For Unknown Indication |
4.1% |
| Affect Lability |
3.4% |
| Attention Deficit/hyperactivity Disorder |
2.7% |
| Febrile Convulsion |
2.7% |
| Bipolar I Disorder |
2.0% |
| Cerebral Infarction |
2.0% |
| Partial Seizures |
2.0% |
| Schizophrenia |
2.0% |
| Brain Oedema |
1.4% |
| Gastric Ulcer |
1.4% |
| Hyperkinesis |
1.4% |
| Ill-defined Disorder |
1.4% |
| Insomnia |
1.4% |
| Vitamin Supplementation |
1.4% |
| Anger |
0.7% |
| Constipation |
0.7% |
|
| Rhabdomyolysis |
10.8% |
| Tic |
10.8% |
| Rash |
8.1% |
| Stevens-johnson Syndrome |
8.1% |
| Toxic Epidermal Necrolysis |
8.1% |
| Liver Disorder |
5.4% |
| Nasopharyngitis |
5.4% |
| Psychomotor Skills Impaired |
5.4% |
| Systemic Lupus Erythematosus |
5.4% |
| Tonic Clonic Movements |
5.4% |
| White Blood Cell Count Decreased |
5.4% |
| Blood Bilirubin Increased |
2.7% |
| Carnitine Decreased |
2.7% |
| Pyrexia |
2.7% |
| Status Epilepticus |
2.7% |
| Vomiting |
2.7% |
| Vulval Disorder |
2.7% |
| Vulval Ulceration |
2.7% |
| White Blood Cell Count Increased |
2.7% |
|
| Concomitant |
| Epilepsy |
44.9% |
| Drug Use For Unknown Indication |
13.1% |
| Schizophrenia |
6.5% |
| Bipolar Disorder |
4.2% |
| Complex Partial Seizures |
4.2% |
| Product Used For Unknown Indication |
4.2% |
| Convulsion |
3.4% |
| Partial Seizures |
2.8% |
| Bipolar I Disorder |
2.5% |
| Constipation |
2.0% |
| Glioblastoma Multiforme |
1.8% |
| Insomnia |
1.5% |
| Back Pain |
1.2% |
| Depression |
1.2% |
| Medulloblastoma Recurrent |
1.2% |
| Neurogenic Bladder |
1.2% |
| Tonic Convulsion |
1.2% |
| Prophylaxis |
1.1% |
| Cardiac Disorder |
0.9% |
| Hallucination |
0.9% |
|
| White Blood Cell Count Decreased |
19.5% |
| Convulsion |
13.3% |
| Somnolence |
6.2% |
| Status Epilepticus |
6.2% |
| Epilepsy |
4.4% |
| Interstitial Lung Disease |
4.4% |
| Meningitis Aseptic |
4.4% |
| Rash |
4.4% |
| Stevens-johnson Syndrome |
4.4% |
| Drug Eruption |
3.5% |
| Drug Rash With Eosinophilia And Systemic Symptoms |
3.5% |
| Hypoxia |
3.5% |
| Pneumonia |
3.5% |
| Blood Potassium Increased |
2.7% |
| Depressed Level Of Consciousness |
2.7% |
| Hepatic Function Abnormal |
2.7% |
| Inappropriate Antidiuretic Hormone Secretion |
2.7% |
| Po2 Decreased |
2.7% |
| Post Procedural Haemorrhage |
2.7% |
| Restlessness |
2.7% |
|
| Interacting |
| Lennox-gastaut Syndrome |
63.2% |
| Hyperammonaemia |
15.8% |
| Epilepsy |
10.5% |
| Pulmonary Hypertension |
10.5% |
|
| Status Epilepticus |
60.0% |
| Drug Interaction |
40.0% |
|
